RT Journal Article
SR Electronic
T1 Rate of tuberculosis screening and isoniazid prophylaxis treatment among human immunodeficiency virus patients in Obio/Akpor Local Government Area: A retrospective study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2023.01.26.23285062
DO 10.1101/2023.01.26.23285062
A1 Edoja, Precious Ruth
A1 Apugo, Uchechukwu Ifeanyichukwu
A1 Anekwe, Ekenedilichukwu Chukwudubem
YR 2023
UL http://medrxiv.org/content/early/2023/01/26/2023.01.26.23285062.abstract
AB Background The co-occurrence of Tuberculosis (TB) and Human Immunodeficiency Virus (HIV) has been recognised as a global public health problem with considerable mutual interaction and a leading cause of death worldwide.Aim To determine the rate of TB screening among People Living with HIV (PLWH) and treatment with isoniazid (INH) prophylaxis in directly observed treatment short course (DOTS) clinics in Primary Healthcare centres (PHCs) in Obio/Akpor Local Government Area of Rivers state.Materials and Method This clinic-based, two-year retrospective cross-sectional study involved a complete review and abstraction of all records for HIV patients (18 years and above) who have been receiving HIV care and treatment for at least 6 months prior to the study in DOTS clinics in five selected PHCs in OBALGA. The data were extracted using a checklist while the statistical analysis of the study was carried out using SPSS version 23.Results The proportion of HIV-positive patients screened for TB was 79.8% while those who had TB diagnostic evaluation among them was 38.6%, and 38.7% of the HIV/TB co-infected patients were placed on INH prophylaxis.Conclusion Insufficient attention is being paid to TB diagnostic evaluation and IPT. Hence, it is recommended that the PHCs in the LGA should be equipped with appropriate devices for TB diagnosis as well as engage the Healthcare Workers in sensitization workshops on the need for continuous screening of PLWH for TB.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study did not receive any fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee/IRB of Full University of Port Harcourt gave ethical approval for this workI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors